Pharmacist Follow-up, a Qualitative Study of Patient Experience

Overview

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Full Title of Study: “Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: March 2010

Detailed Description

See full publication on http://www.biomedcentral.com/1756-0500/7/197 Garcia et al. BMC Research Notes 2014, 7:197

Arms, Groups and Cohorts

  • Study group
    • Patients who are included in the pharmacist follow-up procedure

Clinical Trial Outcome Measures

Primary Measures

  • Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients
    • Time Frame: 3 months or 1 year
    • In the pharmacist follow-up procedure under development, patients have individual “consultations” with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients’ experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant’s/interviewee’s sayings. Outcomes will be presented as overall themes touched by the informants.

Participating in This Clinical Trial

Inclusion Criteria

  • must have met the pharmacist at least twice – living within the area of Tromsoe city so that interviews are possible Exclusion Criteria – none as patients are already enrolled in another study

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hospital Pharmacy of North Norway Trust
  • Collaborator
    • University of Tromso
  • Provider of Information About this Clinical Study
    • Principal Investigator: Beate Hennie Garcia, PhD, Associate Professor – Hospital Pharmacy of North Norway Trust
  • Overall Official(s)
    • Lars Smaabrekke, PhD, Principal Investigator, University of Tromso
    • Beate H Garcia, PhD, Study Chair, Hospital Pharmacy of North Norway Trust

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.